Evaluating the effect of curcumex supplement on the symptoms of patients with COVID-19

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230125057216N1

Enrollment

100

Registered

2023-09-26

Start date

2023-03-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: In the intervention group, 30 patients were treated with Curcumex, which is a combination of three ingredients (320 mg of turmeric, 150 mg of ginger, and 4 mg of bl

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: ground glass opacity in lung CT scan Clinical symptoms such as dry cough- dyspnea-fever- weakness- diarrhea- headache-rhinorrhea- or history of contact with COVID19 patient or recent travel to high-risk areas Positive Covid-19PCR

Exclusion criteria

Exclusion criteria: PO intolerance Dissatisfaction for Participation in research

Design outcomes

Primary

Measure	Time frame
Investigation of the improvement rate of clinical symptoms of patients including cough, dyspnea, weakness, fever and diarrhea one month after take medication. Timepoint: At the beginning of the study and one month later. Method of measurement: history and physical examination.	—

Secondary

Measure	Time frame
White blood cell counts. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;ESR. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;CRP. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;Comparison of the effect of Curcumex treatment on changes in serum creatinine. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;Comparison of the effect of Curcumex treatment on changes in liver enzymes. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.	—

Measure

Time frame

White blood cell counts. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;ESR. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;CRP. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;Comparison of the effect of Curcumex treatment on changes in serum creatinine. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.;Comparison of the effect of Curcumex treatment on changes in liver enzymes. Timepoint: At the beginning of the study and after 30 days from the start of taking medication. Method of measurement: lab data.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Houshmand

Mazandaran University of Medical Sciences

Dr.houshmand_pharmaco@yahoo.com+98 11 3354 3081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026